PharmaLedger December 2021 #4 Press Release
PharmaLedgers December 2021 press release covers key achievements of the project’s second year and its plan for the next stage of the project.
PharmaLedger’s Key 2021 Achievements
- Platform architecture foundation is in place and being tested
- Technical Development of demonstrators for PharmaLedger’s eight use cases
- Growing brand recognition and engagement on social channels, as well as event participation
- New collaboration with industry members and service providers of the consortium
- Innovative Medicines Initiative (IMI) review confirmed that our project completed all activities, deliverables and milestones to date.
Outlook
Read the full press release to find out more about the key objectives for 2022.
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 853992. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.
Disclaimer: Any information on this presentation solely reflects the author’s view and neither IMI nor the European Union or EFPIA are responsible for any use that may be made of the information contained herein.